These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunotherapy with bacille Calmette-Guérin in patients with superficial transitional cell carcinoma of the bladder associated with bilharziasis. Wishahi MM; Ismail IM; el-Sherbini M Br J Urol; 1994 Jun; 73(6):649-54. PubMed ID: 8032832 [TBL] [Abstract][Full Text] [Related]
25. [Progression and recurrence in the prostate and upper urinary tract following intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer]. Wakabayashi Y; Okada Y; Mukumoto K; Hamaguchi A; Konishi T; Tomoyoshi T Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2146-51. PubMed ID: 8309122 [TBL] [Abstract][Full Text] [Related]
26. [Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: study on significance of additional maintenance instillations of bacillus Calmette-Guerin]. Yabusaki N; Komatsu H; Tago K; Yamada Y; Ueno A Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):290-6. PubMed ID: 1904120 [TBL] [Abstract][Full Text] [Related]
27. The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin. deKernion JB; Huang MY; Lindner A; Smith RB; Kaufman JJ J Urol; 1985 Apr; 133(4):598-601. PubMed ID: 3981707 [TBL] [Abstract][Full Text] [Related]
28. The response of patients with superficial bladder cancer to a second course of intravesical bacillus Calmette-Guerin. Bretton PR; Herr HW; Kimmel M; Whitmore WF; Laudone V; Oettgen HF; Fair WR J Urol; 1990 Apr; 143(4):710-2; discussion 712-3. PubMed ID: 2313796 [TBL] [Abstract][Full Text] [Related]
29. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
30. Immunoprophylaxis of superficial bladder cancer: a prospective and randomized comparison of oral versus intravesical Bacillus Calmette-Guerin. Netto Júnior NR; Levi d'Ancona CA; Claro JF; Ilari O Arch Esp Urol; 1991 Oct; 44(8):1025-8. PubMed ID: 1796850 [TBL] [Abstract][Full Text] [Related]
31. Use of maintenance intravesical bacillus Calmette-Guérin (BCG), with or without intradermal BCG, in patients with recurrent superficial bladder cancer. Long-term follow-up of a randomized phase 2 study. Witjes JA; Fransen MP; van der Meijden AP; Doesburg WH; Debruyne FM Urol Int; 1993; 51(2):67-72. PubMed ID: 8351757 [TBL] [Abstract][Full Text] [Related]
32. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin. Linn R; Klimberg IW; Wajsman Z J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508 [TBL] [Abstract][Full Text] [Related]
33. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269 [TBL] [Abstract][Full Text] [Related]
34. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer. Demkow T; Alter A; Wiechno P Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238 [TBL] [Abstract][Full Text] [Related]
35. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. Pansadoro V; Emiliozzi P; Defidio L; Donadio D; Florio A; Maurelli S; Lauretti S; Sternberg CN J Urol; 1995 Dec; 154(6):2054-8. PubMed ID: 7500457 [TBL] [Abstract][Full Text] [Related]
37. Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview. Witjes JA; vd Meijden AP; Debruyne FM Urol Int; 1990; 45(3):129-36. PubMed ID: 2190404 [TBL] [Abstract][Full Text] [Related]
38. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. Hillyard RW; Ladaga L; Schellhammer PF J Urol; 1988 Feb; 139(2):290-3. PubMed ID: 3339727 [TBL] [Abstract][Full Text] [Related]
39. [Intravesical bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder tumors: effect of intravesical BCG on papillary tumors]. Hagiwara M; Asano T; Iigaya T; Tsukamoto T; Nishida K Nihon Hinyokika Gakkai Zasshi; 1986 Oct; 77(10):1623-30. PubMed ID: 3820900 [No Abstract] [Full Text] [Related]
40. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]